Eli Lilly and Company (NYSE:LLY – Get Free Report) and JCR Pharmaceuticals (OTCMKTS:JCRRF – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst recommendations, earnings and institutional ownership. Profitability This table compares Eli Lilly […]
EQS-News: Formycon AG / Key word: Preliminary Results/Forecast
Convincing overall performance - Formycon reports preliminary results for the financial year 2023 and exceeds.
EQS-News: Formycon AG / Key word(s): Preliminary Results/ForecastConvincing overall performance - Formycon reports preliminary results for the financial year 2023 and exceeds forecast 12.04.2024 / 22:15 CET/CESTThe issuer is solely responsible for the content of this announcement.Press release // 12 April 2024 .
EQS-News: Formycon AG / Key word(s): Market LaunchFormycon announces commercial launch of FYB201 (Ranibizumab) in Canada (RanoptoTM) and Switzerland (Ranivisio®) 11.04.2024 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press release // April 11, 2024 Formycon announces co.
EQS-News: Formycon AG / Key word: Market Launch
Formycon announces commercial launch of FYB201 in Canada and Switzerland
11.04.2024 / 07:30 CET/CEST
The issuer is.